Want to keep track of the largest startup funding deals in 2024 with our curated list of $100 million-plus venture deals to U.S.-based companies? Check out The Crunchbase Megadeals Board.

This is a weekly feature that runs down the week’s top 10 announced funding rounds in the U.S. Check out last week’s biggest funding rounds here.

The week was slightly slower for huge rounds compared to previous ones, but half of the funding deals broke the $100 million mark. However, it still was not all that bad for big rounds, especially considering the huge $700 million raised by a food delivery company.

1. Wonder, $700M, food delivery: Marc Lore’s food delivery startup Wonder is back on this list again after making it last November and in June 2022. Wonder raised a whopping $700 million in its latest round. Investors in the deal — which was reportedly raised as a simple agreement for future equity, which has no valuation set — included NEA, GV, Accel and Bain Capital Ventures, among others. Lore himself reportedly invested $100 million. The company aims to open 100 more locations over the next two years. It currently has 11 locations in the New York City area that offer takeout and delivery from several restaurants cooked in a single kitchen. The New York-based firm has been pretty busy of late. In September, Wonder acquired meal-kit company Blue Apron for $103 million. Founded in 2018, Wonder has raised nearly $1.8 billion, per Crunchbase.

2. Mirador Therapeutics, $400M, biotech: More big biotech raises this week. The biggest was for San Diego-based Mirador, which launched with a $400 million Series A funding led by Arch Venture Partners. The company was founded by CEO Mark McKenna and executives from Prometheus Biosciences, which was acquired by Merck in 2023. With breakthroughs in genetics and machine learning, the company is focused on precision medicine for chronic inflammation and fibrotic disease.

3. Capstan Therapeutics, $175M, biotech: Capstan Therapeutics raised a $175 million Series B led by RA Capital Management. The San Diego-based biotechnology company focuses on vivo reprogramming of cells through RNA delivery to combat autoimmune disorders. Founded in 2021, the company says it has raised $340 million.

4. Engrail Therapeutics, $157M, biotech: Anxiety, depression and post-traumatic stress disorder are serious diseases in which therapies can be somewhat limited. Engrail Therapeutics locked up a fresh $157 million Series B co-led by new investors F-Prime Capital, Forbion and Norwest Venture Partners to help expand offerings to combat those problems. The San Diego-based biotech startup focuses on neuropsychiatric and neurodevelopmental diseases and will use the fresh cash to advance its pipeline through clinical development. Since being founded in 2019, Engrail has raised over $220 million, per the company.

5. Clasp Therapeutics, $150M, biotech: Clasp Therapeutics is the next biotech to raise huge. The Cambridge, Massachusetts-based startup is developing T cell engagers tailored to each patient’s immune system to target tumors. The company launched this week with a $150 million financing led by Catalio Capital Management, Third Rock Ventures and Novo Holdings.

6. Foundry, $80M, cloud: While AI may be dominating business, the amount of compute available and its cost are still a hindrance to many. Foundry locked up $80 million — at a reported $350 million valuation — and came out of stealth this week to help with that. The Palo Alto, California-based startup unveiled its public cloud purpose-built for ML workloads. The company says its mission is to “ensure humanity maximizes the utility of the computing power we already have, and will produce.” The newly announced round was co-led by Sequoia Capital and Lightspeed Venture Partners.

7. (tied) BigID, $60M, cybersecurity: New York-based data privacy startup BigID raised a $60 million round led by Riverwood Capital. Founded in 2016, BigID has raised $320 million, per the company.

7. (tied) Figure Markets, $60M, fintech: San Francisco-based Figure Markets, a platform where investors can trade a wide range of blockchain-native assets, raised a more than $60 million Series A led by Jump Crypto, Pantera Capital and Lightspeed Faction. It was the company’s first announced round.

9. Succinct, $55M, Web3: San Francisco-based Succinct raised $55 million across a seed and Series A funding led by crypto investor Paradigm. Founded in 2022, the company builds open-source infrastructure for blockchain applications.

10. Hippocratic AI, $53M, healthcare: Palo Alto, California-based AI healthcare agent developer Hippocratic AI raised a $53 million Series A co-led by PremjiInvest and General Catalyst. Founded in 2022, the company has raised $118 million, per Crunchbase.

Big global deals

The U.S. dominated in terms of big rounds this week. The biggest round outside the U.S. barely broke $100 million.

• Germany-based Solaris, an embedded finance platform, raised a Series F worth approximately $104 million.

Methodology

We tracked the largest announced rounds in the Crunchbase database that were raised by U.S.-based companies for the seven-day period of March 16 to 22. Although most announced rounds are represented in the database, there could be a small time lag as some rounds are reported late in the week.

Illustration: Dom Guzman